INTRODUCTION
diseases (29) . Moreover, enterococci are noted for their capacity to exchange genetic 1 information, including antibiotic resistance genes, by conjugation (12, 15).
2
In this study, a two-peptide bacteriocin (enterocin C) produced by E. faecalis C901, a 3 strain originally isolated from human colostrum provided by a healthy woman, was 4 biochemical and genetically characterized. In addition, this strain was screened for the presence 5 of potential virulence determinants and for its sensitivity to several clinically-relevant 6 antibiotics. 
MATERIALS AND METHODS

9
Bacterial strains and media. E. faecalis C901 and all the bacterial strains used as 10 indicators in this study (Tables 1 and 2 ) were grown routinely in MRS medium (Oxoid, 11 Basingstoke, Hampshire, England) at 37ºC, with the exception of Actinomyces sp.,
12
Enterococcus gallinarum, E. saccharolyticus, Escherichia coli, Staphylococcus sp. and
13
Streptococcus sp., which were grown in Brain Heart Infusion (BHI) medium (Oxoid). All the 14 strains from human sources (Table 1) belonged to our own collection while those from food 15 origin were obtained from different bacterial collections (Table 2 ). They were maintained as 16 frozen stocks at -80ºC in MRS or BHI (Oxoid) plus 20% (vol/vol) glycerol. was assayed by using the agar drop diffusion test as described previously (31), using the strains 21 listed in Tables 1 and 2 as indicator microorganisms. Subsequently, E. faecalis L1443 was used 22 as the indicator strain throughout the whole process of enterocin C purification and, also, to 23 investigate the complementary activity of the two peptides (EntC1 and EntC2) that integrate 24 enterocin C. For the late purpose, 5-µl aliquots of purified EntC1 were mixed with equal volumes of purified EntC2, and the mixes were assayed for antimicrobial activity by the agar 1 drop diffusion test. Five-µl aliquots of each purified peptide were separately assayed in order to 2 compare the results. Quantification of complementary activity among peptides EntC1 and 3 EntC2 of enterocin C was carried out by the microtiter plate assay system (21). The inhibitory 4 activity was expressed as bacteriocin units per millilitre (BU/ml) as described previously (31).
6
Bacteriocin purification. All the purification steps were carried out at room 7 temperature, and all of the chromatographic equipment and media were purchased from 8 Amersham Biosciences Europe GmbH (Freiburg, Germany). Peptides EntC1 and EntC2 were 9 purified from a 2-L culture of E. faecalis C901. After 24 h at 37ºC without shaking, cells were 10 removed by centrifugation at 10,000 × g for 10 min at 4ºC and, then, the bacteriocin was 11 purified from the CFS using the procedure described by Maldonado et al. (30) . Briefly, the CFS 12 was precipitated with ammonium sulfate, desalted, and consecutively applied to cation-13 exchange and hydrophobic-interaction columns. Finally, samples were subjected to C 2 /C 18 14 reverse-phase chromatography in FPLC (RPC-FPLC). Fractions showing inhibitory activity 15 after the C 2 /C 18 reverse-phase column were pooled and subjected to several runs until both degradation with a Beckman LF3000 sequencer/phenylthiohydantoin amino acid analyzer 1 (System Gold, Beckman, Fullerton, CA). Molecular mass of the peptides was determined by PCR sequencing and location of the enterocin C structural and immunity genes.
7
The primer pair 1071A-for (5'-ATGAAGCAATATAAAGTATTGAATG -3') and 1071I-rev 8 (5'-TTACTTAATTAAATAGTTCAGTACA -3') were designed on the basis of the genes 9 encoding Ent1071A (ent1071A) and Ent1071B (ent1071B) and their immunity protein (entI)
10
(GenBank accession number: AF458698). DNA was amplified in 25-µl reaction mixtures 11 containing 2.5 mM Mg Cl 2 , 1× reaction buffer, 200 µM concentrations of each of the 12 deoxynucleotides triphosphates (dNTPs), 1 µM of each of the primers, and 1,25 U of Taq DNA 13 polymerase (Ecotaq; Ecogen, Barcelona, Spain). Amplification included denaturation at 94ºC 14 for 4 min, followed by 30 cycles of denaturation at 94ºC for 30 s, annealing at 56ºC for 1 min, 15 polymerization at 72ºC for 1 min, and a final polymerization step at 72ºC for 5 min.
16
The amplified fragment was excised from a 0.7% agarose gel, purified using the 17 Nucleospin Extract II kit (Macherey-Nagel, Düren, Germany), and both strands were 18 sequenced using primers 1071A-for and 1071I-rev at the Genomics Unit of the Universidad
19
Complutense (Madrid, Spain).
20
To locate the genes encoding EntC1 and EntC2 peptides, PCR assays were performed as 21 described above, using plasmid or chromosomal DNA from E. faecalis C901 as templates.
22
Plasmid DNA was extracted as described by Anderson and McKay (2) 3,899 respectively (4). These results suggested that the amino acid sequence of peptide EntC1
10
could be identical to that of Ent1071A while the differences in the molecular masses between
11
EntC2 and Ent1071B could be attributable to a variation in their amino acid sequence.
13
Genetic analysis and DNA sequencing of enterocin C structural genes. In order to 14 analyse the DNA sequence encoding enterocin C, a 786-bp DNA fragment was amplified with 15 primers 1071A-for/1071I-rev using DNA from pENTC, a 9-kb size plasmid extracted from E. were identical to those described for Ent1071A and Ent1071B, respectively. and EntC2, whose activity is clearly complementary, it has been described that enterocin 8 1071A acts independently from enterocin 1071B (5). In addition, it has been highlighted that 9 the absence of activity against lactococci is a typical feature of enterocins 1071A and 1071B (4, 10 5, 19). However, enterocin C shows inhibitory activity against L. lactis strains including L.
11 lactis IL1403 (Tables 1 and 2 ), a strain resistant to enterocin 1071 (4). In the same manner,
12
enterocin C was active against L. sakei NCFB 2714 but not against L. salivarius NCFB 2747,
13
two strains which were resistant and sensitive, respectively, to enterocin 1071 (4). Therefore, 14 the inhibitory spectrum of enterocin C appears to be quite distinct to that of enterocin 1071. is noticeable that the amphiphilic regions of lactococcins Gβ and Qβ are highly similar to that 12 of EntC2 when represented as an α-helical wheel (Fig. 5) , despite the differences in their 13 aminoacid sequences (Fig. 3) underlined. Theoretical (t) and experimental (e) molecular weights are indicated. Polar and nonpolar amino acid residues are shown as white or shaded circles, respectively.
9
Residues which are different in enterocin EntC2 with respect to enterocin Ent1071B, and in 10 lactococcin  LcnQβ to lactococcin LcnGβ are marked with boxes. a Abbreviations: C, colostrums; H, faeces; EV, vaginal exudates; FR, rectal frotis; M, meconium; L, breast milk; LA, amniotic liquid; P, skin; SC, umbilical cord blood. 
